Aviva PLC Boosts Holdings in Stryker Corporation (SYK)
Aviva PLC raised its stake in Stryker Corporation (NYSE:SYK) by 2.6% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 209,048 shares of the medical technology company’s stock after buying an additional 5,330 shares during the period. Aviva PLC owned approximately 0.06% of Stryker Corporation worth $29,014,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Bollard Group LLC grew its position in Stryker Corporation by 0.4% during the 2nd quarter. Bollard Group LLC now owns 832 shares of the medical technology company’s stock worth $115,000 after purchasing an additional 3 shares in the last quarter. James Investment Research Inc. purchased a new position in Stryker Corporation during the 2nd quarter worth approximately $155,000. Guardian Life Insurance Co. of America grew its position in Stryker Corporation by 0.8% during the 1st quarter. Guardian Life Insurance Co. of America now owns 1,199 shares of the medical technology company’s stock worth $158,000 after purchasing an additional 9 shares in the last quarter. Assetmark Inc. grew its position in Stryker Corporation by 0.3% during the 1st quarter. Assetmark Inc. now owns 1,274 shares of the medical technology company’s stock worth $168,000 after purchasing an additional 4 shares in the last quarter. Finally, Mosaic Family Wealth LLC grew its position in Stryker Corporation by 3.5% during the 1st quarter. Mosaic Family Wealth LLC now owns 1,300 shares of the medical technology company’s stock worth $171,000 after purchasing an additional 44 shares in the last quarter. 74.13% of the stock is currently owned by institutional investors.
Several equities analysts have weighed in on the stock. Zacks Investment Research cut shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, August 17th. BidaskClub cut shares of Stryker Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. Oppenheimer Holdings, Inc. set a $148.00 price objective on shares of Stryker Corporation and gave the stock a “hold” rating in a research report on Friday, July 28th. Jefferies Group LLC reiterated a “hold” rating and set a $132.00 price objective on shares of Stryker Corporation in a research report on Friday, June 30th. Finally, Cowen and Company reiterated a “buy” rating and set a $160.00 price objective (up from $150.00) on shares of Stryker Corporation in a research report on Sunday, July 30th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and twelve have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $145.73.
Shares of Stryker Corporation (SYK) opened at 143.04 on Wednesday. The company has a 50-day moving average of $143.56 and a 200-day moving average of $138.98. Stryker Corporation has a one year low of $106.48 and a one year high of $148.84. The company has a market capitalization of $53.51 billion, a PE ratio of 31.93 and a beta of 0.81.
Stryker Corporation (NYSE:SYK) last released its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.51 by $0.02. The business had revenue of $3.01 billion during the quarter, compared to the consensus estimate of $2.98 billion. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The firm’s revenue for the quarter was up 6.1% compared to the same quarter last year. During the same quarter last year, the firm earned $1.39 earnings per share. On average, analysts anticipate that Stryker Corporation will post $6.46 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Investors of record on Friday, September 29th will be given a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a yield of 1.19%. The ex-dividend date is Thursday, September 28th. Stryker Corporation’s dividend payout ratio (DPR) is currently 37.95%.
In related news, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction on Friday, August 4th. The shares were sold at an average price of $146.36, for a total value of $731,800.00. Following the completion of the transaction, the insider now owns 88,207 shares of the company’s stock, valued at $12,909,976.52. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Graham A. Mclean sold 1,124 shares of the firm’s stock in a transaction on Tuesday, August 8th. The shares were sold at an average price of $146.26, for a total transaction of $164,396.24. Following the completion of the transaction, the insider now directly owns 8,983 shares of the company’s stock, valued at approximately $1,313,853.58. The disclosure for this sale can be found here. In the last ninety days, insiders sold 25,429 shares of company stock valued at $3,686,927. 7.40% of the stock is owned by insiders.
Stryker Corporation Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK).
Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.